Leadless Pacing: Therapy, Challenges and Novelties

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


Leadless pacing is a rapidly growing field. Initially designed to provide right ventricular pacing for those who were contraindicated for conventional devices, the technology is growing to explore the potential benefit of avoiding long-term transvenous leads in any patient who requires pacing. In this review, we first examine the safety and performance of leadless pacing devices. We then review the evidence for their use in special populations, such as patients with high risk of device infection, patients on haemodialysis, and patients with vasovagal syncope who represent a younger population who may wish to avoid transvenous pacing. We also summarise the evidence for leadless cardiac resynchronisation therapy and conduction system pacing and discuss the challenges of managing issues, such as system revisions, end of battery life and extractions. Finally, we discuss future directions in the field, such as completely leadless cardiac resynchronisation therapy-defibrillator devices and whether leadless pacing has the potential to become a first-line therapy in the near future.

Original languageEnglish
Article numbere09
JournalArrhythmia and Electrophysiology Review
Publication statusPublished - 10 May 2023


Dive into the research topics of 'Leadless Pacing: Therapy, Challenges and Novelties'. Together they form a unique fingerprint.

Cite this